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N ¼ 22 (%)
Median age at diagnosis 66.8
Male 12 (55)
PAD 13 (59)
CAD 13 (59)
CVA/TIA 5 (23)
HTN 17 (77)
CHF 5 (23)
Diabetes 9 (41)
Smoker 16 (76)
Thrombophilia 5 (23)
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Objectives: Rupture after EVAR is a function of long-term graft dura-
bility and function. We describe our 10-year experience with rupture after
EVAR.
Methods: Between 2000 and 2010 1736 patients with AAA under-
went EVAR in a large, regional integrated health care system and 20 cases
of rupture after EVAR were identiﬁed. We examined risk factors associated
with “early” (<30 days after the initial EVAR) and “late” ($30 days
following the initial EVAR) rupture.
Results: The overall follow-up rate was 92%, and the median follow-
up was 2.7 years (IQR, 1.2-4.4 years). Among the 20 ruptures, 70% were
male, mean age was 79 years, AAA size at initial EVAR was 6.3 cm, and
6 patients underwent primary EVAR for rupture (n ¼ 3) or symptomatic
(n ¼ 3) presentation. Of the 20 ruptures after primary EVAR, 25% (5/
20) were “early” ruptures, all occurring within 2 days following the primary
EVAR. Of these 5 patients, 4 had intraoperative adverse events leading
directly to rupture, with 1 type I and 1 type III leak. Of the 5 “early”
ruptures, 4 underwent endovascular repair and 1 was repaired open, result-
ing in 2 perioperative deaths. Among the remaining 15 patients, the mean
time to “delayed” rupture was 36.6 6 27.5 months (Table). Most patients
had AAA sac increases prior to rupture with some patients having known
endoleaks or having undergone reintervention. At the time of delayed
rupture 12 of 15 patients were found to have new endoleaks. Six patients
did not undergo repair, while 9 underwent redo EVAR and 5 had open
repair.
For those patients who underwent repair for delayed rupture, survival
at 30 days and 1 year were 61.5% and 38.5%, respectively. Multivariate
analysis identiﬁed age >80 (HR, 3.5; CI, 1.1-11.0; P < .05), and urgent
EVAR (HR, 7.1; CI, 2.1-24.6; P <.01) as signiﬁcant predictors of delayed
rupture.
Conclusions: Rupture after EVAR is a rare but devastating event and
mortality after repair is high. The majority of delayed cases showed late AAA
expansion, thereby implicating acute device-related failures as the cause of
rupture in these patients and mandating vigilant surveillance. Future efforts
are needed to identify more sensitive predictors of rupture and graft dura-
bility after EVAR.Table.
Characteristics of 20 ru
Characteristic Early (n ¼ 5)
Sac expansion 0/5 (0%)
Known endoleak (type) 2/5, 40% (1 type 1, 1 typ
Endoleak at time of rupture (type) n ¼ 2 (1 type I, 1 type II
Prior attempt at endoleak repair 0
Endovascular repair at time of rupture
presentation
4/5 80%
Open repair at time of rupture presentation 1/5 (20%)
CMO status at time of rupture presentation 0/5
30-day survival 60%
1-year survival 40%
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Objectives: Acute aortic occlusion (AAO) is rare with the last large
series published in 1998 which included patients dating back to the
1980’s. These studies report that 50% of AAOs secondary to embolization
with an approximate mortality rate of 50%. We reviewed our recent experi-
ence with AAO to identify current etiologies and outcomes in a modern era.
Methods: CPT codes were used to identify patients with AAO from
2005-2012 from a prospectively maintained surgical database. AAOs
secondary to trauma, dissection or endograft occlusion were excluded.
Results: We identiﬁed 22 patients with AAO as outlined in Table.
Seventeen presented with isolated occlusion and ﬁve with occlusion extending
above the renal arteries. Signiﬁcant lower extremity neurologic deﬁcits were
noted in 12 patients, six with complete paralysis. Mean time from symptom
onset to diagnosis was 36 hours (range, 6-72 hours). 16 (73%) presented to our
institution as a transfer. Etiology was aortoiliac thrombosis in 17 (77%) cases,
embolic occlusion in 1, and indeterminate in 4. Extra-anatomic bypass was
performed in 14 patients, thromboembolectomy in 4 and aortobifemoral
bypass in3.Onepatientdiedprior to intervention.Acute renal failuredeveloped
in 14 patients (68%) and eight had rhabdomyolysis. Fasciotomywas performed
in 14 (68%) extremities and nine extremities required amputation (41%). All
cause mortality was 41% with all deaths occurring within 3 months of AAO.
Conclusions: AAO is an infrequent but devastating event. Our expe-
rience demonstrates that the etiology of AAO the etiology has shifted fromptures after EVAR
Delayed (n ¼ 15)
P value
(Fisher's exact)
13/15 (86%) .001
e 3) 6/15, 40% (2 type I, 5 type II, 1 type III
(some had more than one leak)
.99
I) n ¼ 12 (8 type I, 1 type II, 3 type III) .500
4/15 (26%) (1 redo EVAR, 3 angiograms) .233
9/15 (60%) .576
5/15 (33%) .516
6/15 (40%) .121
61.5% NS
38.5% NS
